Dormant
RPAY · Repay Holdings Corporation
Last analysed ·
Resolved Graded and closed 2026-09-18 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
The Visa-headline pop has round-tripped — $4.01 on 2026-08-21 back to $3.88 on 2026-09-04 — while the deal file stayed silent: the only company items since are an 2026-08-26 NxtEdge AP partnership and a 2026-09-03 IR hire, leaving Forager's rejected $5.25 cash proposal roughly 26% above the tape, a maturing activist narrative and no dated catalyst before the ~November Q3 print.
Kill line
A weekly close below $3.45 erases the June revised-bid re-rating and puts price under the entire post-Q2 shelf. Secondarily, a Forager 13D/A withdrawing the $5.25 proposal or converting to Schedule 13G removes the bid anchor the discount is quoted from.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for RPAY —
As of 20 September 2026, the latest FrontierPicks analysis for Repay Holdings Corporation (RPAY): The Visa-headline pop has round-tripped — $4.01 on 2026-08-21 back to $3.88 on 2026-09-04 — while the deal file stayed silent: the only company items since are an 2026-08-26 NxtEdge AP partnership and a 2026-09-03 IR hire, leaving Forager's rejected $5.25 cash proposal roughly 26% above the tape, a maturing activist narrative and no dated catalyst before the ~November Q3 print.
Kill line: A weekly close below $3.45 erases the June revised-bid re-rating and puts price under the entire post-Q2 shelf. Secondarily, a Forager 13D/A withdrawing the $5.25 proposal or converting to Schedule 13G removes the bid anchor the discount is quoted from.
Current Thesis
Repay Holdings’ activist revaluation thesis requires the market to reach Forager’s rejected $5.25 cash proposal before a weekly close below $3.45 breaks the case. The 2026-09-18 adjusted close of $3.98 approaches the 2026-08-21 close of $4.01 cited in the September 6 dossier, but the company’s release index still ends with its 2026-09-03 investor-relations appointment. Price has recovered toward that earlier reference without a newly announced transaction in the reviewed company record. REPAY news releases
The narrative is maturing — the company acknowledged the initial approach on 2026-04-17, rejected the revised proposal on 2026-07-13, and lists no subsequent transaction announcement through the 2026-09-20 review. This is an inference about the campaign’s progression, not evidence that a transaction is approaching. A signed agreement would replace the unresolved-proposal thesis with a different, contractual case. Initial proposal, revised-proposal rejection
Bullish and bearish views on Repay Holdings Corporation
The model's bull view on Repay Holdings Corporation (RPAY), in brief: A specific cash proposal exists. REPAY confirmed Forager’s non-binding $5.25-per-share proposal on 2026-06-29. That supplies an observable reference for the activist thesis; it does not establish an executable transaction or a market floor. Company acknowledgment Operating cash… The bear view: The board rejected the proposed valuation. Both cases follow in full.
Bull Case
- A specific cash proposal exists. REPAY confirmed Forager’s non-binding $5.25-per-share proposal on 2026-06-29. That supplies an observable reference for the activist thesis; it does not establish an executable transaction or a market floor. Company acknowledgment
- Operating cash generation supports scrutiny. The 2026-08-10 results reported second-quarter revenue of $100.705 million and free cash flow of $27.4 million. Management reiterated fiscal 2026 revenue guidance of $490–500 million; a reduction below the lower end would contradict the standalone operating support for the revaluation case. Second-quarter results
- Distribution agreements broaden the operating story. REPAY announced Visa Platform Connect participation on 2026-08-19 and the NxtEdge partnership on 2026-08-26. The September 6 dossier recorded no disclosed financial terms, so neither announcement establishes an incremental revenue forecast. Company release index
Bear Case
- The board rejected the proposed valuation. The 2026-07-13 rejection was unanimous, and the proposal was explicitly non-binding. Treating $5.25 as assured proceeds would contradict the company’s description of the offer. Board announcement
- The operating case carries leverage. The 2026-08-10 results and accompanying call reported a second-quarter net loss of $11.5 million and pro forma net leverage of 3.7 times. A subsequent increase in reported net leverage would weaken the case that cash generation is reducing financial constraints. Second-quarter results
- The calendar supplies no resolution date. As reviewed on 2026-09-20, REPAY’s events page lists no upcoming event. The absence of a company-dated catalyst leaves the timing of proposal resolution unestablished. REPAY events
Setup & Price Structure
The supplied adjusted market series records a $3.98 daily close on 2026-09-18, a three-month price increase of 25.2%, and a 14-period relative strength index (RSI) of 58.8. Those measurements describe price appreciation and momentum; they do not identify the participants responsible. The $4.01 close on 2026-08-21 remains a historical comparison point, rather than a verified resistance zone derived from a complete chart.
Public ownership records identify Forager’s reported 12.4% interest in its 2026-06-29 Schedule 13D amendment and Veradace’s reported 8.2% interest in its 2026-06-04 amendment. These are dated third-party disclosures, not measurements of current buying pressure. Disclosed ownership records
A current moving-average value, trading-volume series and retail-sentiment sample are missing. The available observations therefore do not support a claim that participation is expanding or that the shares are crowded. The low-conviction forecast reflects the unresolved, rejected proposal and the empty company calendar reviewed on 2026-09-20.
Catalyst Calendar (next 30 days)
- 2026-09-20 through 2026-10-20: No company-confirmed event appears on REPAY’s events page as reviewed on 2026-09-20. An amended activist filing could change the proposal’s status, but no date is established for one. Company calendar
- ~2026-11-09, est.: The existing September 6 dossier’s provisional third-quarter reporting date remains unconfirmed; REPAY has not listed the event. This later operating checkpoint matters because it can test the $490–500 million fiscal 2026 revenue outlook reiterated on 2026-08-10. It supplies no transaction deadline. Company calendar, August results
What Would Change Our Mind
Loss of the previously published June revaluation boundary would break the price thesis: a weekly close below $3.45 in the adjusted market series is the condition retained from the 2026-09-06 dossier. That is an analytical boundary, not a newly measured moving average. The defined successful outcome is a market close at or above the $5.25-per-share proposal disclosed on 2026-06-29 before that boundary is breached. Proposal acknowledgment
A Forager filing explicitly withdrawing the proposal would remove the transaction reference. Separately, fiscal 2026 revenue guidance below the $490 million lower bound reiterated on 2026-08-10 would contradict the operating support for revaluation. A signed definitive acquisition agreement would instead require reassessment around its disclosed terms and completion conditions. August outlook
Correlation Notes
This is a single-name special situation: the 2026-07-13 board rejection is specific to REPAY, and the supplied 2026-09-18 price snapshot contains no peer-return series. No measured correlation with payments stocks, consumer-credit equities or broader acquisition activity can be stated. The theme tags describe business and event exposures; they do not establish a group-driven price move. Board rejection
Notes
- roughly 21% of the register sits with 13D filers, so stance changes arrive as public filings.
- The $5.25 Forager proposal is non-binding, carries no stated expiry, and the company has announced no strategic-alternatives process.
- Directors are elected under plurality voting: the ~36-37% withhold at the 2026-06-10 annual meeting unseated no one and cannot on its own.
- KUBRA ($372M, closed 2026-06-01) was funded with a $500M floating-rate senior secured term loan led by Silver Point Capital plus a $100M undrawn revolver.
- Published analyst targets run $5.00 to $12.00; the five-analyst consensus figure is $6.85 (stockanalysis.com, 2026-09-06). Coverage is thin enough that one revision moves the mean.
- Market cap $342.16M on 88.18M shares outstanding (2026-09-06) — small-cap liquidity constrains how large a view can be expressed without moving the print.
Related · shared themes
DAVE
Dave Inc.
Dave Inc.'s growth-and-credit-quality recovery case is invalidated by the September 18, 2026 weekly close of $337.82 below its published $358 boundary. JPMorgan's September 15 initiation adds favorable coverage but does not reverse that outcome.
SEZL
Sezzle Inc.
Sezzle's profitable-growth recovery thesis requires a daily close above $129.87 before a weekly close below $114 invalidates it. The 2026-09-18 adjusted close of $116.55 lost the August shelf again, reversing the intermediate repair described on September 11.
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.